Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States

Globalization and Health

Volumn 2, Issue , 2006, Pages

  Zhang, Ruifang ^a   Eggleston, Karen ^b   Rotimi, Vincent ^c   Zeckhauser, Richard J ^d  

^a Goldman Sachs Group   (United States)

^b TUFTS UNIVERSITY   (United States)

^c KUWAIT UNIVERSITY   (Kuwait)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFACLOR; CEFOTAXIME; CEFPROZIL; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METICILLIN; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; PIPERACILLIN; QUINOLONE DERIVATIVE; SPARFLOXACIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; GROWTH RATE; HEALTH HAZARD; HOSPITAL INFECTION; HUMAN; KUWAIT; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

EID: 33746077145     PISSN: 17448603     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-8603-2-6     Document Type: Article

References (35)

1. Kimball AM, Arima Y, Hodges RH: Trade related infections: farther, faster, quieter. Globalization and Health 2005, 1:3.
2. Hodges RH, Kimball AM: The global diet: trade and novel infections. Globalization and Health 2005, 1:4.
3. Wilson KH, Blitchington RB: Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 62(7):2273-2278.
4. Institute of Medicine: Emerging infections: microbial threats to health in the United States. National Academy Press 1994.
5. Wilson KH, Blitchington RB: Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 62(7):2273-8.
6. Davies J: Bacteria on the rampage. Nature 1996, 383:219-220.
7. Field HJ, Coen DM: Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene. J Virol 1986, 60(1):286-289.
8. Muder RR, Brennen C, Wagener MM, et al.: Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patients in Calcutta: a 3-year (1993-1995) analysis. J Clin Microbiol 1996, 34:2537-2543.
9. Bisognano C, et al.: Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 1997, 41(5):906-913.
10. World Health Organization: WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva 2001.
11. Arason VA, Kristinsson KG, et al.: Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 1996, 313:387-91.
12. Seppala H, Klaukka T, et al.: The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997, 337:441-6.
13. Levy SB, Fitzgerald GB, Macone AB: Spread of Antibiotic-Resistant Plasmids from Chicken to Chicken and from Chicken to Man. Nature 1976, 260(5546):40-42.
14. Levy SB, Fitzgerald GB, Macone AB: Changes in Intestinal Flora of Farm Personnel after Introduction of a Tetracycline-Supplemented Feed on a Farm. N Engl J Med 1976, 295:583-588.
15. Witte W: Selective pressure by antibiotic use in livestock. Int J Antimicrob Agents 2000, 16(Suppl 1):S19-24. Review
16. Breathnach AS, de Ruiter A, Holdsworth GM, et al.: An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect 1998, 39(2):111-117.
17. Hannan MM, Azadian BS, Gazzard BG, et al.: Hospital infection control in an era of HIV infection and multi-drug resistant tuberculosis. J Hosp Infect 2000, 44(1):5-11.
18. Martin MA: Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen. Curr Clin Top Infect Dis 1994, 14:170-191.
19. Wang F, Zhu D, et al.: Surveillance of bacterial resistance in Shanghai. Chin J Infect Chemother 2002, 2(1):1-9.
20. Cox RA, Conquest C, Malaghan C, et al.: A major outbreak of methicillin-resistant Staphylococcus aureus caused by new phage-type (EMRSA-16). J Hosp Infect 1995, 29:87-106.
21. Astagneau P, et al.: Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey. J Hosp Infect 1999, 42:303-312.
22. Haley RW, Morgan WM, Culver DH, et al.: Update from the SENIC project. Hospital infection control: Recent progress and opportunities under prospective payment. Am J Infect Control 1985, 13:97-108.
23. Duckworth GJ: Diagnosis and management of methicillin-resistant Staphylococcus aureus infection. British Medical Journal 1993, 307:1049-1052.
24. Tsiodras S, Gold H, et al.: Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001, 358:207-208.
25. Chen H, Ma Y, National Antimicrobial Resistance Surveillance Center, et al.: The Changing Patterns of Ciprofloxacin Resistant Bacteria Strains Isolated from Fifty Hospitals in China from 1994 to 2000. Chin J Infect Chemotherapy 2002, 2(4):43-45.
26. Li J, Li G, Wang J: Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections. Natl Med J China 2003, 83(5):365-374. (in Chinese)
27. Li J, Li G, Wang J: Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections. Natl Med J China 2003, 83(12):1035-1045. (in Chinese)
28. National Nosocomial Infections Surveillance System 2001 [http://www.cdc.gov/ncidod/hip/SURVEILL/nnis_pubs.HTM.]. report
29. National Antimicrobial Resistance Monitoring System for Enteric Bacteria 2002 [http://www.cdc.gov/narms/]. report
30. Active Bacterial Care Surveillance 2001 [http://www.cdc.gov/ ncidod/dbmd/ abcs/reports.htm.]. report
31. Eggleston KE, Rotimi V, Ghayda A, Zhang R, Zeckhauser RJ: An economic analysis of antimicrobial resistance in Kuwait. J Antimicrobial Chemotherapy. Forthcoming
32. Neuhauser MM: Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003, 289(7):885-888.
33. Sun Z: Antimicrobial resistance and clinical interventions. Adverse Drug Reaction J 2003, 3:151-155.
34. McDonald LC, Lauderdale T, et al.: The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme 2000. Int J Antimicrob Agents 2004, 23(4):362-370.
35. Fidler DP: Globalization, international law, and emerging infectious diseases. Emerg Infect Dis 1996, 2(2):77-84.